Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$894,893,598
+$296,245,659 QoQ
Shares Held
746,099
+14.6% QoQ
Ownership
0.079%
of shares outstanding
% of Portfolio
1.22%
of 13F equity value
Holder Rank
#90
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JONES FINANCIAL COMPANIES LLLP holds $2,915,385,555 across 19 Drug Manufacturers - General names. LLY ranks #1 (30.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
746,099 | $894,893,598 | |
| 2 | JNJ |
Johnson & Johnson
|
1,814,780 | $460,899,675 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,548,737 | $327,512,704 | |
| 4 | AZN |
Astrazeneca PLC
|
1,670,876 | $316,831,506 | |
| 5 | NVS |
Novartis AG
|
1,974,043 | $309,372,018 | |
| 6 | ABBV |
AbbVie Inc.
|
988,813 | $248,824,903 | |
| 7 | PFE |
Pfizer Inc
|
4,638,683 | $111,699,485 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
502,809 | $63,524,888 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $894,893,598 | 746,099 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $598,647,939 | 650,867 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $253,528,856 | 235,911 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $166,769,673 | 218,571 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $147,002,207 | 188,578 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $123,627,989 | 149,687 | Shares | Sole | 2025-05-28 | |
| 2024-12-31 | $87,764,820 | 113,685 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $77,246,879 | 87,192 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $48,140,864 | 53,172 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $14,035,176 | 18,041 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $5,260,269 | 9,024 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $3,790,526 | 7,057 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,719,949 | 7,932 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $2,791,317 | 8,128 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $3,059,885 | 8,364 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,743,301 | 8,484 | Shares | Defined | 2022-11-03 | |
| 2022-06-30 | $2,991,345 | 9,226 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $2,796,975 | 9,767 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $2,828,769 | 10,241 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,745,120 | 7,553 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,908,688 | 8,316 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,419,832 | 7,600 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $1,098,979 | 6,509 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $837,348 | 5,657 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $1,096,558 | 6,679 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $910,557 | 6,564 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||